About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us



Investor Relations: Investor Packet Request


8/29/2014 - Daxor Corporation Announces Filing of Form N-CSR for June 30, 2014


6/19/2014 - Daxor to Explore Possible Partnership or Partial Sale of the Company


5/30/2014 - Heart Failure Study From the Mayo Clinic Utilizing Daxor’s BVA-100 Blood Volume Analyzer Published in Journal of the American College of Cardiology – Heart Failure



  Form N-CSR for Jun 30, 2014  
  Form N-Q for Mar 31, 2014  
  Form NSAR-B for Dec 31, 2013  
  Form N-Q for Sep 30, 2013  

Please fill in the following form to have your request e-mailed to DAXOR Corporation. One of our staff will contact you promptly.

Address 1:
Address 2:
ZIP/postal code
Telephone number:
E-mail address:
Message or






350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2014 DAXOR Corporation. All Rights Reserved.